Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

• John Pradeep Veluchamy,

  Affiliations Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands, Glycostem Therapeutics, Oss, The Netherlands

  http://orcid.org/0000-0002-5681-1860

  ⨯
• Jan Spanholtz,

  Affiliation Glycostem Therapeutics, Oss, The Netherlands

  ⨯
• Marleen Tordoir,

  Affiliation Glycostem Therapeutics, Oss, The Netherlands

  ⨯
• Victor L. Thijssen,

  Affiliation Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands

  ⨯
• Daniëlle A. M. Heideman,

  Affiliation Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Henk M. W. Verheul,

  Affiliation Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands

  ⨯
• Tanja D. de Gruijl,

  Affiliation Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands

  ⨯
• Hans J. van der Vliet

  * E-mail: jj.vandervliet@vumc.nl

  Affiliation Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands

  ⨯